"Our experience and competence is
 focused on helping you to succeed"

Ms. Funato has over 17 years of sales and marketing experience in the biotechnology field, encompassing the pharma, government and academic spheres. The latter nine years of these were spent in positions of increasing responsibility at the Japanese branch of a leading U.S. company serving the life science research and clinical diagnostic markets. She received her degree in business management from the Institute of Management at Sanno University and in molecular biology from Tokyo Technical College.

Mr. Mac Síomóin received his M.Sc. from the Institute of Medical Science of the University of Tokyo and his B.Sc. from the Moyne Institute of Preventative Medicine at Trinity College, Ireland. Research areas include infectious diseases and metabolic disease marker discovery. He has also worked in a major Japanese pharmaceutical company on projects to develop new bio-therapeutics, and in-licensing of innovative therapeutic candidates. More recently he served as Business Development Manager at Amersham Biosciences Japan (now GE Healthcare), creating new businesses via strategic alliances with overseas drug discovery companies for the Japanese market. Mr. Mac Síomóin has been resident in Japan for 15 years.

Dr. Anderson is a U.K.-based expert in neuro-psychological disorders. She is currently a Head of Psychological Services in the National Health Service, and acts as Honorary Secretary to the Division of Clinical Psychology Scotland (British Psychological Society). Dr. Anderson frequently contributes to major policy papers for the British Psychological Society and the Scottish Executive Health Department. She is also a visiting lecturer at the University of Edinburgh. Dr. Anderson received her Ph.D. in Clinical Psychology from Trinity College (University of Dublin) and B.A. from Cornell University, New York, U.S.A.

Mr. Shinozaki received his degree from the Faculty of Law at Chuo University. He is active in the financial and taxation fields and is a member of the Japan Federation of Certified Public Tax Accountants’ Associations.

Dr. Sasakawa is the professor of the Department of Microbiology and Immunology at the Institute of Medical Science, University of Tokyo. He is an internationally-acclaimed expert in bacterial pathogenesis and infectious diseases and has authored over 200 scientific papers, articles and reviews. The scope of his scientific work has included the development of vaccines. He is a member of numerous advisory and editorial boards, including that of the prestigious Nature Review of Microbiology. Professor Sasakawa was previously a Forgaty NIH Fellow at the Washington University School of Medicine　(U.S.A.).

Dr. Burmer is a highly distinguished medical pathologist with a particular interest in the application of molecular pathology to drug discovery. In 1995 she co-founded LifeSpan Biosciences (U.S.A.), a global leader in the molecular pathology field, and has served as its Executive Vice President and Chief Scientific Officer since inception. Prior to this, Dr. Burmer was Director of New Pathogen Discovery at Pathogenesis Corporation (U.S.A.), directing a large team of scientists that discovered the association of HHV-6 with multiple sclerosis. Dr. Burmer has served as Assistant Professor of Pathology and Director of the DNA Probe Laboratory at the University of Washington. She earned her M.D. and Ph.D. from the University of Washington Medical School and completed her internship, residency, and post-doctoral work at the same University.

Mr. Masuoka has a long business development and management career in the medical/biotechnology area. He spent 16 years at the Japanese subsidiary of a leading U.S. clinical diagnostics company, involved in sales and marketing. This was followed by several years as senior manager and CEO of multiple foreign medical device firms. More recently, Mr. Masuoka has served as CEO of Nippon Bio-Rad, where he oversaw 13 years of continuous business growth. He is currently the CEO of a microchemical technology firm. Mr. Masuoka graduated from the Waseda University Faculty of Political Science and Economics.

Mr. Hase has over 25 years of business experience at senior management level. He is a former director of ACOM, one of Japan's largest consumer finance organizations, and has been involved in the establishment and management of numerous other companies in a wide range of business areas. He currently acts as CEO for 4 firms within the ACOM group. Mr. Hase holds a degree from the Faculty of Law at Meiji Gakuin University.